|
|
|
Insider
Information: |
George Jean |
Relationship: |
Director |
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
25,063 |
|
Indirect Shares
|
9,489,849 |
|
|
Direct
Value |
$959,184 |
|
|
Indirect Value
|
$172,603,750 |
|
|
Total
Shares |
9,514,912 |
|
|
Total
Value |
$173,562,934 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2013-05-28 |
0 |
2013-05-28 |
8,632 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
2020-01-22 |
5,127 |
2019-06-28 |
0 |
Premium* |
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2015-07-22 |
5,786 |
2014-07-31 |
0 |
Premium* |
|
Calithera Biosciences, Inc. |
CALA |
Director, 10% Owner |
2014-10-07 |
0 |
2014-10-07 |
2,110,082 |
Premium* |
|
Astria Therapeutics, Inc |
ATXS |
Director |
2015-06-30 |
0 |
2015-06-30 |
90,764 |
Premium* |
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
|
0 |
2021-02-05 |
4,836,106 |
Premium* |
|
Cyteir Therapeutics, Inc. |
CYT |
Director |
2024-02-14 |
14,150 |
2024-02-14 |
2,444,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2013-11-14 |
4 |
S |
$12.22 |
$49,185,500 |
I/I |
(4,025,000) |
3,876,221 |
0 |
- |
|
CYT |
Cyteir Therapeutics, Inc. |
Director |
|
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,444,268 |
2,444,268 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2013-09-24 |
4 |
A |
$0.00 |
$0 |
I/I |
2,280,245 |
2,513,783 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Former 10% Owner |
|
2014-01-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,988,813) |
33,969 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2014-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,810,082 |
1,810,082 |
0 |
- |
|
ATXS |
Astria Therapeutics, Inc |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,632,076 |
78,342 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2013-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,543,280 |
8,632 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-09-30 |
4 |
S |
$35.50 |
$30,428,648 |
I/I |
(857,145) |
453,505 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-11-17 |
4 |
S |
$38.05 |
$16,047,318 |
I/I |
(420,576) |
0 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2014-10-07 |
4 |
B |
$10.00 |
$3,000,000 |
I/I |
300,000 |
2,110,082 |
2.25 |
- |
|
ATXS |
Astria Therapeutics, Inc |
Director |
|
2015-06-30 |
4 |
B |
$12.00 |
$3,105,312 |
I/I |
258,776 |
90,764 |
2.1 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2013-09-24 |
4 |
A |
$0.00 |
$0 |
I/I |
223,806 |
2,449,764 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2014-05-05 |
4 |
S |
$42.86 |
$9,242,502 |
I/I |
(215,644) |
1,939,031 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-07 |
4 |
OE |
$5.88 |
$747,477 |
I/I |
127,122 |
127,122 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2017-12-15 |
4 |
S |
$35.73 |
$3,756,009 |
I/I |
(105,122) |
0 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2014-12-08 |
4 |
S |
$45.33 |
$4,021,338 |
I/I |
(88,629) |
1,814,434 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2019-06-26 |
4 |
OE |
$24.11 |
$988,175 |
D/D |
37,500 |
41,250 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-11-16 |
4 |
S |
$41.39 |
$1,362,931 |
I/I |
(32,929) |
420,576 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2014-07-31 |
4 |
S |
$20.09 |
$585,779 |
I/I |
(29,157) |
0 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2019-06-26 |
4 |
S |
$39.16 |
$1,005,942 |
D/D |
(25,688) |
15,562 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Former 10% Owner |
|
2014-01-21 |
4 |
S |
$22.35 |
$531,378 |
I/I |
(23,780) |
10,495 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
Director |
|
2016-12-07 |
4 |
D |
$33.98 |
$747,560 |
I/I |
(22,000) |
105,122 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Former 10% Owner |
|
2014-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
19,893 |
19,893 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2014-11-03 |
4 |
AS |
$25.15 |
$439,629 |
D/D |
(17,483) |
0 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2014-11-03 |
4 |
OE |
$5.06 |
$103,722 |
D/D |
17,483 |
17,483 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|